Genomictree Inc. (KOSDAQ:228760)

Genomictree Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 26, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	503,531	490,598	486,819	181,477	270,356	292,798
Market Cap Growth	19.26%	0.78%	168.25%	-32.88%	-7.66%	-37.53%
Enterprise Value	420,699	396,622	392,442	88,761	154,638	186,950
Last Close Price	20750.00	20450.00	20600.00	8790.00	13300.00	14650.00
PS Ratio	133.96	207.68	142.43	6.08	52.60	236.35
PB Ratio	4.34	3.95	3.89	1.69	2.35	3.07
P/TBV Ratio	4.39	4.00	3.95	1.72	2.39	3.10
P/FCF Ratio	-	-	-	71.93	-	-
P/OCF Ratio	-	-	-	42.35	-	-
EV/Sales Ratio	111.92	167.90	114.82	2.97	30.09	150.91
EV/EBITDA Ratio	-	-	-	23.73	-	-
EV/EBIT Ratio	-	-	-	36.90	-	-
EV/FCF Ratio	-29.23	-	-	35.18	-	-
Debt / Equity Ratio	0.02	0.02	0.02	0.27	0.33	0.12
Debt / EBITDA Ratio	-	-	-	7.80	-	-
Debt / FCF Ratio	-	-	-	11.57	-	-
Net Debt / Equity Ratio	-0.72	-0.76	-0.73	-0.79	-0.80	-0.96
Net Debt / EBITDA Ratio	7.40	6.66	5.66	-22.84	10.43	7.96
Net Debt / FCF Ratio	5.77	5.83	8.21	-33.86	4.95	7.09
Asset Turnover	0.03	0.02	0.02	0.18	0.04	0.01
Inventory Turnover	8.05	7.48	6.57	10.63	3.48	1.59
Quick Ratio	17.01	20.35	17.77	2.17	62.01	25.28
Current Ratio	17.19	20.56	18.06	2.21	62.71	25.75
Return on Equity (ROE)	-7.41%	-8.33%	-7.75%	-5.60%	-10.86%	-11.49%
Return on Assets (ROA)	-6.04%	-7.26%	-7.31%	0.88%	-4.17%	-6.70%
Return on Capital Employed (ROCE)	-10.50%	-12.20%	-13.60%	2.20%	-5.60%	-10.90%
Earnings Yield	-1.74%	-2.09%	-1.80%	-3.65%	-4.23%	-4.03%
FCF Yield	-2.86%	-3.28%	-2.28%	1.39%	-6.88%	-4.42%
Buyback Yield / Dilution	-0.88%	9.92%	-26.28%	-1.68%	-3.30%	-4.57%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.